Skip to main content

Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S

Press Release   •   Jan 29, 2018 09:07 GMT

Christoffer Lorenzen (42) is Executive Vice President (EVP) of Chr. Hansen’s largest business unit, Food Cultures & Enzymes. He joined Chr. Hansen in March 2008 and has held various positions in Sales and Marketing, including Director of Marketing in our Animal Health & Nutrition Business, and Vice President of Central & Eastern Europe. In 2013 he was appointed Senior Vice President of Commercial Development in the Cultures & Enzymes Division and in 2016 he was appointed EVP of the Food Cultures and Enzymes Business Unit.

Prior to joining Chr. Hansen, Mr Lorenzen was employed at H. Lundbeck A/S, a global specialty pharmaceutical company, where he served as Head of Corporate Strategy and M&A as well as Corporate Secretary.

Christoffer Lorenzen holds a Master in Business (Marketing) 2002 from the Copenhagen Business School.

“The appointment of Christoffer Lorenzen to the Executive Board of Chr. Hansen had been planned already before the announcement of Cees de Jong stepping back, as FC&E has normally always been represented at the Executive Board.” says Ole Andersen Chairman of Chr. Hansen.

CEO Cees de Jong adds: “Christoffer has been with Chr. Hansen for the past 10 years and has a deep knowledge and understanding of the company, its history and its potential. By joining, Christoffer adds core knowledge and expertise to the Executive Board.”

The company strategy, priorities and financial guidance remain the same.

As of 1 February, 2018, the Executive Board consists of: CEO Cees de Jong, CFO Søren Westh Lonning, CSO Thomas Schäfer, and EVP Christoffer Lorenzen. The Executive Board is appointed by the Board of Directors and is, together with their colleagues in the Corporate Leadership Team, responsible for day-to-day management and compliance with the guidelines and directions given by the Board of Directors.

For further information, please contact:
Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50
Helle Rexen, Interim Head of Media Relations, Tel: +45 20 74 28 40

Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2016/17 financial year was EUR 1,063 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.

Comments (0)

Add comment

Comment

Agree With Privacy Policy